Hedge Fund Manager Buys Rights To Critical Drug, Hikes Price By 5000%

Back to story content.

MOST POPULAR

Contact Advertise with AlterNet Privacy Policy Writer Guidelines Press Information About AlterNet Meet the AlterNet Staff Debug Logs

@2026 - AlterNet Media Inc. All Rights Reserved. - "Poynter" fonts provided by fontsempire.com.